Literature DB >> 309708

Natural history and life expectancy in severe alpha1-antitrypsin deficiency, Pi Z.

C Larsson.   

Abstract

Clinical data from 246 adult Swedish individuals with severe alpha1-antitrypsin deficiency, Pi Z, diagnosed in 1963--77, were analyzed. Primary emphysema was present in 109 cases. Of 75 Pi Z patients with other types of chronic obstructive pulmonary disease (COPD), all but 7 showed signs of emphysema. Median age at onset of dyspnoea in Pi Z smokers was 40 years, compared to 53 in non-smokers (p less than 0.001). Of the Pi Z individuals over the age of 50, 19% had a diagnosis of liver cirrhosis and 15% signs of glomerular renal damage. Of 91 deceased patients, 56 died from COPD and 12 from liver disease. A greatly reduced survival was demonstrated in Pi Z individuals, regardless of sex. Smoking Pi Z individuals had a significantly lower life expectancy than Pi Z non-smokers (p less than 0.01).

Entities:  

Mesh:

Year:  1978        PMID: 309708     DOI: 10.1111/j.0954-6820.1978.tb08452.x

Source DB:  PubMed          Journal:  Acta Med Scand        ISSN: 0001-6101


  105 in total

Review 1.  Alpha-1-antitrypsin deficiency: what next?

Authors:  R A Stockley
Journal:  Thorax       Date:  2000-07       Impact factor: 9.139

Review 2.  Alpha-1 antitrypsin deficiency.

Authors:  R A Primhak; M S Tanner
Journal:  Arch Dis Child       Date:  2001-07       Impact factor: 3.791

3.  Alpha(1)-Antitrypsin Deficiency.

Authors: 
Journal:  Curr Treat Options Gastroenterol       Date:  2000-12

Review 4.  Alpha-1 antitrypsin deficiency: a commonly overlooked cause of lung disease.

Authors:  Sarah K Brode; Simon C Ling; Kenneth R Chapman
Journal:  CMAJ       Date:  2012-07-03       Impact factor: 8.262

5.  [Hereditary hemochromatosis, alpha-1-antitrypsin deficiency and Wilson's disease. Pathogenesis, clinical findings and pathways to diagnosis].

Authors:  H Zhou; H-P Fischer
Journal:  Pathologe       Date:  2008-02       Impact factor: 1.011

Review 6.  Protein misfolding and the serpinopathies.

Authors:  Didier Belorgey; Peter Hägglöf; Susanna Karlsson-Li; David A Lomas
Journal:  Prion       Date:  2007-01-06       Impact factor: 3.931

Review 7.  Genetics and respiratory disease. 2. Alpha 1-antitrypsin deficiency, cirrhosis and emphysema.

Authors:  R Mahadeva; D A Lomas
Journal:  Thorax       Date:  1998-06       Impact factor: 9.139

8.  Alpha 1-antitrypsin phenotypes in acute anterior uveitis.

Authors:  I R Fearnley; D J Spalton; A M Ward; B Slavin; F Muncey
Journal:  Br J Ophthalmol       Date:  1988-08       Impact factor: 4.638

9.  Alpha 1-antitrypsin screening of 18-year-old men.

Authors:  T Sveger; P Mazodier
Journal:  Thorax       Date:  1979-06       Impact factor: 9.139

Review 10.  Current status of alpha-1-antitrypsin replacement therapy: recommendations for the management of patients with severe hereditary deficiency. Ad Hoc Committee on Alpha-1-Antitrypsin Replacement Therapy of the Standards Committee, Canadian Thoracic Society.

Authors: 
Journal:  CMAJ       Date:  1992-03-15       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.